Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00086385 · ClinicalTrials.gov registry record · Phase 3
Maintaining Nonsmoking: Older Smokers - 1
A Phase 3 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 3
- Development phase
- 403
- Enrollment target
NCT00086385 is a Phase 3 study that has completed, run by University of California, San Francisco. The registered enrollment target is 403 participants.
The verdict
NCT00086385, a Phase 3 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 403 participants
- Enrollment target
Study Summary
The purpose of this study was to examine pharmacological and psychological interventions for smokers over 50.
Interventions
- DRUG Nicotine polacrilex, Bupropion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 403 participants |
| Start Date | 2001-09 |
| Est. Completion | 2009-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00086385
The ClinicalTrials.gov registry entry for NCT00086385 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 403 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nicotine polacrilex, Bupropion is the first listed.
NCT00086385 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00086385 about?
NCT00086385 is a clinical study titled "Maintaining Nonsmoking: Older Smokers - 1". The purpose of this study was to examine pharmacological and psychological interventions for smokers over 50.
What is the current status of trial NCT00086385?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 403 participants. The study started on 2001-09. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00086385?
The interventions under investigation include: Nicotine polacrilex, Bupropion (DRUG).
Who is sponsoring clinical trial NCT00086385?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.